Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950142-08-000355
Filing Date
2008-02-14
Accepted
2008-02-14 12:28:26
Documents
1
Group Members
HARRI V. TARANTOMARK KESSELSYMPHONY CAPITAL GP, L.P.SYMPHONY CAPITAL PARTNERS, L.P.SYMPHONY GP, LLCSYMPHONY STRATEGIC PARTNERS, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 sc13ga1_isis.htm SC 13G/A 188870
  Complete submission text file 0000950142-08-000355.txt   190714
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Subject) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-41771 | Film No.: 08611329
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 PARK AVE APT. 11A NEW YORK NY 10028
Business Address
KESSEL MARK (Filed by) CIK: 0001222013 (see all company filings)

Type: SC 13G/A